Equipment Types

Contrast-Enhanced Ultrasound (CEUS)

Finance contrast-enhanced ultrasound systems for liver lesion characterization, cardiac perfusion, and advanced diagnostic applications. Apply today.

Quote My System

Contrast-enhanced ultrasound adds a clinical tier that standard B-mode imaging cannot reach. A microbubble contrast agent injected peripherally reaches the target organ within seconds, and a system with contrast-specific imaging modes captures the enhancement pattern in real time: arterial phase fill-in, portal venous phase washout, or late-phase retention. For liver lesion characterization, that enhancement pattern is diagnostic information that rivals contrast CT in many scenarios, without ionizing radiation and at a fraction of the per-study cost once the system is in place. CEUS is not a niche technology; it is an established diagnostic method with published evidence, CPT billing codes, and active adoption at imaging centers, hepatology practices, and hospital-based radiology departments.

We finance CEUS-capable ultrasound systems for radiology groups, hepatology and gastroenterology programs, outpatient imaging centers, cardiology practices using contrast echocardiography, and academic institutions adding CEUS to their diagnostic portfolio. Our minimum is $50,000, and most platforms configured for CEUS with the necessary software modules and probe package sit comfortably above that threshold.

Clear answers

Questions About Contrast-Enhanced Ultrasound (CEUS)

Review the common timing, documentation, and equipment questions before sending the quote.

Can CEUS software be added to an existing ultrasound system that already runs diagnostic exams?

Some existing systems can be upgraded with a CEUS software module purchased from the manufacturer, but this depends entirely on whether the hardware platform supports contrast imaging. Not all systems do; the imaging electronics need to support non-linear harmonic signal processing. Check with your manufacturer's clinical applications team to confirm whether your specific system supports a CEUS software upgrade before purchasing the module.

Does the contrast agent cost factor into the financing?

Contrast agent (Lumason, Definity, or Optison) is a pharmaceutical supply and cannot be financed as equipment. It is an operating cost billed per study. The system financing covers the hardware and software platform; the contrast agent is a per-case supply expense managed through your pharmacy or supply chain.

We do primarily cardiac echo. Does CEUS work differently for cardiac applications?

Cardiac contrast echo for LVO uses different agents (Definity or Optison rather than Lumason for abdominal) and requires specific cardiac contrast modes on the system software. Most phased-array cardiac imaging platforms from major manufacturers support LVO contrast echo. The setup, administration protocol, and interpretation criteria differ from abdominal CEUS, but the system itself often supports both cardiac and abdominal contrast modes within the same software suite.

Are there training requirements before a facility can offer CEUS services?

Yes. ACR and AIUM guidelines address training and credentialing for CEUS interpretation. Physicians interpreting CEUS studies should complete manufacturer training and review the relevant society guidelines. For practical purposes, major manufacturers include CEUS training as part of their system installation support. This is a clinical and credentialing question rather than a financing one, but practices adding CEUS as a new service should plan the training timeline alongside the equipment timeline.

Keep exploring

Related Financing Paths

Ultrasound equipment desk

Get Contrast-Enhanced Ultrasound (CEUS) scanning.

Share the system model, seller quote, probe package, and desired in-service date. We will respond with the next documentation step.

Quote My SystemCall (615) 455-2651